A bibliometric analysis reveals molecular mechanisms and treatment strategies for colorectal cancer in diabetes populations, highlighting their importance.
Research on the interplay between colorectal cancer and diabetes is gaining increasing priority. Future efforts should focus on elucidating molecular mechanisms-such as oxidative stress and angiogenesis dysregulation-refining epidemiological models, and translating findings into clinical practice. Developing precision medicine strategies for CRC screening and treatment in diabetic populations, alongside the exploration of novel biomarkers and therapeutic targets, will be essential to improve patient prognosis.
No takes yet. Share an insight, caveat, or question.
Long et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: